Pivotal Bio Venture Partners Investment Advisor LLC has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $111 Million distributed in 10 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vaxcyte, Inc. with a value of $49.4M, Arcutis Biotherapeutics, Inc. with a value of $40M, Trevi Therapeutics, Inc. with a value of $11.2M, Immunome Inc. with a value of $5.82M, and Recursion Pharmaceuticals, Inc. with a value of $2.91M.

Examining the 13F form we can see an increase of $4.8M in the current position value, from $106M to 111M.

Pivotal Bio Venture Partners Investment Advisor LLC is based out at San Francisco, CA

Below you can find more details about Pivotal Bio Venture Partners Investment Advisor LLC portfolio as well as his latest detailed transactions.

Portfolio value $111 Million
Healthcare: $111 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 10
  • Current Value $111 Million
  • Prior Value $106 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 1 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Pivotal Bio Venture Partners Investment Advisor LLC Portfolio

Follow Pivotal Bio Venture Partners Investment Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pivotal Bio Venture Partners Investment Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pivotal Bio Venture Partners Investment Advisor LLC with notifications on news.